AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Igantet 250IU Injection

Prescription Icon
Prescription Required

Marketer

Bharat Serums & Vaccines Ltd

Salt Composition

Tetanus Toxoid (250IU)

Overview Igantet 250IU Injection

Tetanus toxoid vaccine, Igantet 250IU, is a preventative injection against tetanus, commonly called lockjaw. A complete childhood vaccination schedule involves four doses, followed by a booster in adolescence. Subsequent booster shots are advised every decade thereafter. Administration must be performed by a qualified healthcare provider; self-injection is strictly prohibited. Complete adherence to the recommended vaccination schedule is crucial for optimal protection. Regular 10-year booster injections maximize vaccine efficacy. Commonly reported side effects include localized injection site reactions (pain, swelling, redness), fever, and decreased appetite. Persistent or worsening side effects warrant immediate medical attention; your physician can provide management strategies to mitigate these symptoms. Prior to vaccination, disclose any pre-existing medical conditions or medications currently being taken to ensure the vaccine's safe administration.

Primary Ingredients of Igantet 250IU Injection

The information is unavailable.

Uses of Igantet 250IU Injection

Avoiding Tetanus

Major Benefits of Igantet 250IU Injection:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

Common Side effects of Igantet 250IU Injection:

  • Injection site reactions (pain, swelling, redness)
  • Loss of appetite
  • Fever

How to use Igantet 250IU Injection:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

How Igantet 250IU Injection works:

Tetanus immunization is achieved with Igantet 250IU Injection. This vaccine triggers a minor, non-disease-causing infection that prompts antibody production, thus building immunity against subsequent tetanus infections.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

Alcohol consumption alongside Igantet 250IU Injection may pose unknown risks. Seek medical advice before combining them.

PregnancyPregnancySAFE IF PRESCRIBED

The injectable medication Igantet 250IU poses minimal to no documented risk to the fetus during gestation, according to the majority of research.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Data on the compatibility of Igantet 250IU Injection with breastfeeding is absent. Seek medical advice from your physician.

DrivingDrivingSAFE

Driving ability is typically unaffected by Igantet 250IU Injection.

KidneyKidneySAFE IF PRESCRIBED

The use of Igantet 250IU Injection in individuals with kidney impairment appears to pose minimal risk. Existing evidence indicates dose modification may be unnecessary; however, physician consultation is recommended.

LiverLiverSAFE IF PRESCRIBED

Igantet 250IU Injection appears to be safely administered to individuals with hepatic impairment. Existing evidence indicates dose modification for Igantet 250IU Injection may be unnecessary in this population; however, medical advice should be sought.

What if you forget to take Igantet 250IU Injection :

Omit a scheduled Igantet 250IU Injection? Seek your physician's guidance.

Facts to Know About Igantet 250IU Injection

LabelValue
Type of Compound Immunizations
Potential for Dependence None.
Treatment Category Immunizations

FAQs on Igantet 250IU Injection

Igantet 250IU Injection confers passive artificial immunity by introducing an attenuated or inactivated pathogen, triggering antibody production and thus an immune response. This vaccination protects against the life-threatening illness, tetanus.
An extra vaccine dose, sometimes called a booster shot or booster vaccine, is an additional injection given after the initial vaccination series for particular illnesses. This supplemental dose is typically required at intervals of a few years to reinforce immunity and maintain sufficient protection against these diseases.
Tetanus, once symptomatic, is incurable; hospital-based care focuses solely on supportive measures and complication management. Prophylactic vaccination remains the most effective tetanus intervention.
Following exposure, the time before symptoms appear ranges between three and twenty-one days, typically averaging eight days. Incubation time increases with the distance of the injury from the central nervous system. A shorter incubation period is associated with a greater mortality risk.
Tetanus manifests as muscle rigidity, including trismus (lockjaw), hindering respiration, oral intake, and swallowing. Igantet 250IU Injection facilitates the body's production of infection-fighting agents against the tetanus-causing bacteria.
Igantet 250IU injections are administered to individuals of all ages, including infants from two months old. A repeat dose is generally advised every decade. Seek medical advice for any vaccination concerns.
Delayed receipt of a scheduled Igantet 250IU Injection booster? Consult your physician promptly to reschedule.
Extensive research and clinical evaluations confirm the safety and efficacy of Igantet 250IU Injection as a vaccine. Consequently, it's received widespread endorsement from global medical authorities and healthcare professionals. Its proven ability to avert potentially fatal illnesses such as tetanus underscores its significant health benefits. Furthermore, Igantet 250IU Injection demonstrates a favorable safety profile, with any adverse reactions typically mild and transient.
Igantet 250IU Injection
1,293
MRP 1,500
13% off